Target Volume Determination 2016

454 / 1031

Intergroup 0139/RTOG 9309
stage IIIA
cispl / etop + RT 45Gy  surgery  cispl / etop x 2
versus
cispl / etop + RT 45Gy  RT 61 Gy  cispl / etop x 2
Inclusion criteria:
― histologically proven N2 T1-3,
― potentially resectable
― operable